French Registry: Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy

Starting soon

Conditions studied: Cardiomyopathy, Hypertrophic Cardiomyopathies

In brief

This study aims to create a registry of patients with hypertrophic cardiomyopathy, a condition characterized by excessive thickening of the heart muscle. This disease can sometimes lead to serious complications. Currently, the prognosis of these patients is mainly determined by clinical and echocardiographic parameters. Detection of myocardial fibrosis using cardiac MRI enables better risk stratification for these patients.

Key facts

Study ID

NCT07428031

Run by

Assistance Publique - Hôpitaux de Paris

People needed

5000

Starts

2026-03-01

Expected to finish

2036-03-01

Last updated by the study team

2026-02-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Ability to provide informed consent
• HCM diagnosis referred for CMR assessment.

You may not qualify if…

• Patients unable to provide informed consent,
• Patients with a history of ischemic cardiomyopathy or myocarditis.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.